Stock listing

NASDAQ:DARE Dare Bioscience, Inc. Stock

Home listing (NASDAQ) of Dare Bioscience, Inc.

Follow Dare Bioscience, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:DARE

$0.655 USD -0.045 (-6.4%)

Close on Nov 2, 2026

Past year -65.9% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
$0.648 – $0.739 USDNov 2, 2026
Volume
206,412 sharesNov 2, 2026
Market cap
$12.88M USDAt the close on Nov 2, 2026 · price × 19.67M shares outstanding
52-week range
$0.625 – $3.780 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
$470,850 USDMedian day 165,800 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Dare Bioscience, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:DARE · Home$0.655 USD-0.045 (-6.4%)206,412$0.739$0.739$0.648$0.700Close on Nov 2, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:DARE · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.655-0.045-6.4%$0.739$0.739$0.648206,412
$0.700+0.018+2.7%$0.703$0.703$0.670651,427
$0.682+0.001+0.2%$0.670$0.698$0.66446,847
$0.680+0.017+2.6%$0.680$0.680$0.66446,109
$0.663+0.019+3.0%$0.643$0.684$0.64351,578
$0.644-0.002-0.3%$0.668$0.675$0.64050,492
$0.646-0.006-0.9%$0.640$0.666$0.63856,543
$0.652-0.036-5.3%$0.685$0.713$0.625327,902
$0.688-0.001-0.1%$0.680$0.712$0.67324,806
$0.689-0.017-2.4%$0.723$0.730$0.670217,694
$0.706-0.019-2.6%$0.727$0.738$0.680251,986
$0.725-0.015-2.0%$0.739$0.740$0.71377,200
$0.740+0.011+1.5%$0.730$0.746$0.72096,900
$0.729-0.019-2.5%$0.743$0.743$0.72061,000
$0.748-0.002-0.3%$0.786$0.786$0.730116,100
$0.750-0.023-3.0%$0.770$0.790$0.73881,600
$0.773+0.001+0.1%$0.790$0.790$0.76069,600
$0.772-0.018-2.3%$0.786$0.800$0.755165,800
$0.790-0.043-5.2%$0.814$0.819$0.790113,200
$0.833-0.010-1.2%$0.830$0.880$0.83088,400
$0.8430.0000.0%$0.833$0.869$0.831157,200
$0.843-0.008-0.9%$0.869$0.878$0.822147,300
$0.851-0.002-0.2%$0.860$0.870$0.830134,800
$0.853+0.038+4.7%$0.800$0.880$0.768277,700
$0.815+0.065+8.7%$0.787$0.867$0.736644,400
$0.750-0.026-3.4%$0.790$0.816$0.701697,300
$0.776+0.035+4.7%$0.770$0.790$0.746119,100
$0.741-0.066-8.2%$0.802$0.846$0.712469,500
$0.807-0.043-5.1%$0.850$0.870$0.80099,700
$0.850+0.040+4.9%$0.810$0.880$0.810245,500
$0.810+0.026+3.3%$0.820$0.840$0.796279,900
$0.784+0.036+4.8%$0.793$0.810$0.766229,200
$0.748+0.022+3.0%$0.745$0.776$0.745153,200
$0.726-0.004-0.5%$0.732$0.759$0.724135,400
$0.730-0.006-0.8%$0.741$0.771$0.720107,200
$0.736+0.030+4.2%$0.706$0.750$0.691426,100
$0.706+0.001+0.1%$0.717$0.723$0.70593,700
$0.705-0.012-1.7%$0.700$0.725$0.700102,500
$0.717+0.004+0.6%$0.729$0.730$0.691173,400
$0.713-0.008-1.1%$0.730$0.737$0.701191,700
$0.721+0.008+1.1%$0.700$0.757$0.700437,500
$0.713-0.027-3.6%$0.751$0.779$0.690450,300
$0.740-0.030-3.9%$0.780$0.797$0.740246,900
$0.770+0.009+1.2%$0.744$0.797$0.730461,200
$0.761+0.026+3.5%$0.760$0.820$0.730639,300
$0.735-0.004-0.5%$0.758$0.758$0.720354,200
$0.739-0.012-1.6%$0.751$0.780$0.730428,500
$0.751-0.070-8.5%$0.833$0.847$0.740952,200
$0.821+0.019+2.4%$0.818$0.854$0.800618,671
$0.802-0.018-2.3%$0.820$0.845$0.800434,896
$0.820+0.011+1.4%$0.800$0.850$0.800345,600
$0.809-0.015-1.8%$0.820$0.860$0.780502,500
$0.824+0.056+7.3%$0.768$0.850$0.762711,600
$0.768-0.042-5.2%$0.825$0.831$0.7501,138,100
$0.810-0.120-12.9%$0.929$0.930$0.8101,950,000
$0.930-0.440-32.1%$1.550$1.610$0.7658,087,900
$1.370-0.070-4.9%$1.430$1.457$1.3106,347,000
$1.4400.0000.0%$1.450$1.468$1.41595,000
$1.440+0.080+5.9%$1.380$1.455$1.380141,900
$1.360-0.040-2.9%$1.400$1.410$1.35047,400
$1.400+0.070+5.3%$1.360$1.420$1.36091,700
$1.330-0.010-0.7%$1.305$1.380$1.30589,900
$1.3400.0000.0%$1.320$1.380$1.30057,300
$1.340+0.060+4.7%$1.290$1.380$1.290133,800
$1.280+0.060+4.9%$1.230$1.340$1.230126,400
Ticker
NASDAQ:DARE
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Dare Bioscience (NASDAQ:DARE) Q2 2026 Earnings Call

    Thu, Aug 13, 2026 · 4:30 PM ET

    Watch Transcript

  • Dare Bioscience (NASDAQ:DARE) Q1 2026 Earnings Call

    Thu, May 14, 2026 · 4:30 PM ET

    Watch Transcript

  • Dare Bioscience (NASDAQ:DARE) Q4 2025 Earnings Call

    Thu, Mar 26, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum

Oct 30, 2026

Closed $0.70 (+2.7%) on Oct 30, 2026

Daré Bioscience Addresses New National Focus on Women’s Health in Virtual Investor “What This Means” Discussion

Oct 28, 2026

Closed $0.68 (+2.6%) on Oct 28, 2026

Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly

Oct 26, 2026

Closed $0.644 (-0.3%) on Oct 26, 2026

Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer

Oct 19, 2026

Closed $0.706 (-2.6%) on Oct 19, 2026

Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting

Oct 8, 2026

Closed $0.772 (-2.3%) on Oct 8, 2026

Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection

Sep 28, 2026

Closed $0.75 (-3.4%) on Sep 28, 2026

Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil

Sep 14, 2026

Closed $0.736 (+4.2%) on Sep 14, 2026

Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand

Sep 11, 2026

Closed $0.706 (+0.1%) on Sep 11, 2026

Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth

Aug 31, 2026

Closed $0.761 (+3.5%) on Aug 31, 2026

Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series

Aug 27, 2026

Closed $0.739 (-1.6%) on Aug 27, 2026

All Dare Bioscience, Inc. news

Financings

  • Registered direct offering of common stock (or pre-funded warrants), with concurrent private placement of Series A and Series B warrants

    Aug 17, 2026

    Announced: US$6M · US$1.37 a share · Warrants at US$1.37 for 60 months · Ladenburg Thalmann & Co. Inc.

    Dealers: Ladenburg Thalmann & Co. Inc. (lead)

    Announced Aug 14, 2026 · Announced Aug 17, 2026

Read by 6ix AI from the company's releases

Decks

Dare Bioscience, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
41 in the last 12 months · 181 in all · newest Oct 30, 2026 · oldest 2019
Calls
20 calls with a replay · 20 with a transcript · latest Aug 13, 2026
Decks
55 decks · latest Oct 1, 2026

Where Dare Bioscience, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:DARE · Home listing · This pageNASDAQUnited StatesUSD
BOATS:DAREBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Dare Bioscience, Inc.